.jpeg "Eli Lilly Wins USFDA Breakthrough for Olomorasib in Lung Cancer Therapy")
Eli Lilly and Company has been given the Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA) for olomorasib combined with anti-PD-1 therapy Keytruda
Poly Medicure, India's largest medical device company announced its acquisition of 90% of the PendraCare Group, including PendraCare Holdings and Wellinq Medical, from Wellinq Holdings B.V. The deal has an enterprise value of €18.3 million...
.jpeg "Sanofi Highlights 31 Abstracts on Inflammatory Respiratory Diseases at ERS")
Sanofi's approved and pipeline medications aimed at addressing significant care gaps in chronic inflammatory respiratory diseases will be showcased at the European Respiratory Society (ERS) International Congress.
.jpeg "Glenmark Initiates Global Phase 3 Trial for Novel Lung Cancer Drug")
Glenmark Pharmaceuticals has also begun a global Phase 3 clinical trial with Envafolimab, a new medication to treat patients with third stage non-small cell lung cancer (NSCLC). The shift highlights the increasing role of India in late-stage drug dev
The Department for Promotion of Industry and Internal Trade (DPIIT), Ministry of Commerce and Industry, has partnered with Pfizer Limited by signing a Memorandum of Understanding
Edwards Lifesciences has launched its new-gen transcatheter heart valve platform in India, marking a significant advance in the treatment of severe aortic stenosis. The system is intended for patients that are not suitable candidates for open-hear...
The GST Council has removed the 12% Goods and Services Tax (GST) on 33 high-cost life-saving drugs and diagnostic kits, resulting in these items being tax-free and thus relieving the burden on patients.
Granules India Limited, in collaboration with the National Institute of Pharmaceutical Education and Research (NIPER), S.A.S Nagar, has officially opened the Dr. Chigurupati Centre of Excellence in Innovative and Sustainable Pharmaceutical
Pharmaceutical company Lupin Ltd today announced that the US Food and Drug Administration (USFDA), granted approval on its generic risperidone LAI extended-release injectable suspension (25 mg, 37.5 mg, and 50 mg single-dose vials) for the...
.jpeg "Novo Nordisk to End rDNA Insulin Product Sales in India")
Novo Nordisk India’s proposal to discontinue several recombinant DNA (rDNA) origin insulin products from the Indian market has been approved by the Subject Expert Committee
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")